V-Set and Transmembrane Domain Containing 2A (VSTM2A) Peptid
VSTM2A
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle VSTM2A Produkte
- VSTM2A (V-Set and Transmembrane Domain Containing 2A (VSTM2A))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- DISHKLQISK VRKKDEGLYE CRVTDANYGE LQEHKAQAYL KVNANSHARR
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of VSTM2 A antibody,
Alternative Names: VSTM2A control peptide, VSTM2A antibody Blocking Peptide, Anti-VSTM2A Blocking Peptide, V-Set And Transmembrane Domain Containing 2A Blocking Peptide, MGC33530 Blocking Peptide, VSTM2 Blocking Peptide, VSTM2A, VSTMA-2, VSTMA 2, VSTMA-2 Blocking Peptide, VSTMA 2 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- VSTM2A (V-Set and Transmembrane Domain Containing 2A (VSTM2A))
- Hintergrund
- This pseudogene is a member of the cytochrome P450 geneuperfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. It is possible that, in rare cases, a combination of two SNPs in this gene may result in an open reading frame encoding a functional enzyme which metabolizes codeine to morphine.
- Molekulargewicht
- 26 kDa
-
Sie sind hier:
